These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8159815)

  • 1. A rational approach to risk assessment requires the use of biological information: an analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors.
    Goodman JI
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):51-9. PubMed ID: 8159815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Center for the evaluation of risks to human reproduction--the first five years.
    Jahnke GD; Iannucci AR; Scialli AR; Shelby MD
    Birth Defects Res B Dev Reprod Toxicol; 2005 Feb; 74(1):1-8. PubMed ID: 15729732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speculations on the rodent carcinogenicity of 30 chemicals currently under evaluation in rat and mouse bioassays organised by the U.S. National Toxicology Program.
    Bootman J
    Environ Mol Mutagen; 1996; 27(3):237-43. PubMed ID: 8625960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity characterization of environmental chemicals by the US National Toxicology Program: an overview.
    Chhabra RS; Bucher JR; Wolfe M; Portier C
    Int J Hyg Environ Health; 2003 Aug; 206(4-5):437-45. PubMed ID: 12971699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP-CERHR expert panel report on the reproductive and developmental toxicity of methanol.
    Shelby M; Portier C; Goldman L; Moore J; Iannucci A; Jahnke G; Donkin S;
    Reprod Toxicol; 2004 May; 18(3):303-90. PubMed ID: 15082073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of reduced protocols for carcinogenicity testing of chemicals: report of a joint EPA/NIEHS workshop.
    Lai DY; Baetcke KP; Vu VT; Cotruvo JA; Eustis SL
    Regul Toxicol Pharmacol; 1994 Apr; 19(2):183-201. PubMed ID: 8041916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism.
    Counts JL; Goodman JI
    Regul Toxicol Pharmacol; 1995 Jun; 21(3):418-21. PubMed ID: 7480895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human carcinogenic risk evaluation, Part V: The national toxicology program vision for assessing the human carcinogenic hazard of chemicals.
    Bucher JR; Portier C
    Toxicol Sci; 2004 Dec; 82(2):363-6. PubMed ID: 15456919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of multispecies testing in industrial toxicology.
    Zbinden G
    Regul Toxicol Pharmacol; 1993 Feb; 17(1):85-94. PubMed ID: 8441831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention and precaution in hazard identification in the NIEHS/NTP: body in the morgue approach.
    Moure-Eraso R
    Public Health Rep; 2002; 117(6):564-73. PubMed ID: 12576536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans?
    Monro A
    Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.